These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 13679362)

  • 21. Combined use of rheology and portable low-field NMR in cystic fibrosis patients.
    Abrami M; Maschio M; Conese M; Confalonieri M; Gerin F; Dapas B; Farra R; Adrover A; Torelli L; Ruaro B; Grassi G; Grassi M
    Respir Med; 2021; 189():106623. PubMed ID: 34624628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.
    Shah PL; Scott SF; Knight RA; Marriott C; Ranasinha C; Hodson ME
    Thorax; 1996 Feb; 51(2):119-25. PubMed ID: 8711640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro.
    Rubin BK; Kater AP; Goldstein AL
    Chest; 2006 Nov; 130(5):1433-40. PubMed ID: 17099021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.
    Suk JS; Lai SK; Wang YY; Ensign LM; Zeitlin PL; Boyle MP; Hanes J
    Biomaterials; 2009 May; 30(13):2591-7. PubMed ID: 19176245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH.
    Hill DB; Long RF; Kissner WJ; Atieh E; Garbarine IC; Markovetz MR; Fontana NC; Christy M; Habibpour M; Tarran R; Forest MG; Boucher RC; Button B
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30361244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis.
    Bush A; Payne D; Pike S; Jenkins G; Henke MO; Rubin BK
    Chest; 2006 Jan; 129(1):118-23. PubMed ID: 16424421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles.
    Abdulkarim M; Agulló N; Cattoz B; Griffiths P; Bernkop-Schnürch A; Borros SG; Gumbleton M
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):230-8. PubMed ID: 25661585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of Pulmozyme activity in purulent sputum by combination with poly-aspartic acid or gelsolin.
    Bucki R; Cruz K; Pogoda K; Eggert A; Chin L; Ferrin M; Imbesi G; Hadjiliadis D; Janmey PA
    J Cyst Fibros; 2015 Sep; 14(5):587-93. PubMed ID: 25682700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug diffusion through cystic fibrotic mucus: steady-state permeation, rheologic properties, and glycoprotein morphology.
    Bhat PG; Flanagan DR; Donovan MD
    J Pharm Sci; 1996 Jun; 85(6):624-30. PubMed ID: 8773960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rheological effects of hypertonic saline and sodium bicarbonate solutions on cystic fibrosis sputum in vitro.
    Budai-Szűcs M; Berkó S; Kovács A; Jaikumpun P; Ambrus R; Halász A; Szabó-Révész P; Csányi E; Zsembery Á
    BMC Pulm Med; 2021 Jul; 21(1):225. PubMed ID: 34253193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucus, phlegm, and sputum in cystic fibrosis.
    Rubin BK
    Respir Care; 2009 Jun; 54(6):726-32; discussion 732. PubMed ID: 19467160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A biophysical basis for mucus solids concentration as a candidate biomarker for airways disease.
    Hill DB; Vasquez PA; Mellnik J; McKinley SA; Vose A; Mu F; Henderson AG; Donaldson SH; Alexis NE; Boucher RC; Forest MG
    PLoS One; 2014; 9(2):e87681. PubMed ID: 24558372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy.
    Forier K; Messiaen AS; Raemdonck K; Deschout H; Rejman J; De Baets F; Nelis H; De Smedt SC; Demeester J; Coenye T; Braeckmans K
    Nanomedicine (Lond); 2013 Jun; 8(6):935-49. PubMed ID: 23035662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheological and transport properties of airway secretions in cystic fibrosis--relationships with the degree of infection and severity of the disease.
    Puchelle E; Jacquot J; Beck G; Zahm JM; Galabert C
    Eur J Clin Invest; 1985 Dec; 15(6):389-94. PubMed ID: 3938409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is cystic fibrosis mucus abnormal?
    King M
    Pediatr Res; 1981 Feb; 15(2):120-2. PubMed ID: 7254936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum.
    Tang JX; Wen Q; Bennett A; Kim B; Sheils CA; Bucki R; Janmey PA
    Am J Physiol Lung Cell Mol Physiol; 2005 Oct; 289(4):L599-605. PubMed ID: 15964901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The many ways sputum flows - Dealing with high within-subject variability in cystic fibrosis sputum rheology.
    Radtke T; Böni L; Bohnacker P; Fischer P; Benden C; Dressel H
    Respir Physiol Neurobiol; 2018 Aug; 254():36-39. PubMed ID: 29684501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of a bacterial alginate lyase to purulent CF sputum in vitro can result in the disruption of alginate and modification of sputum viscoelasticity.
    Mrsny RJ; Lazazzera BA; Daugherty AL; Schiller NL; Patapoff TW
    Pulm Pharmacol; 1994 Dec; 7(6):357-66. PubMed ID: 7549223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA and actin bind and inhibit interleukin-8 function in cystic fibrosis sputa: in vitro effects of mucolytics.
    Perks B; Shute JK
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1767-72. PubMed ID: 11069810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodegradable microparticles designed to efficiently reach and act on cystic fibrosis mucus barrier.
    Cristallini C; Barbani N; Ventrelli L; Summa C; Filippi S; Capelôa T; Vitale E; Albera C; Messore B; Giachino C
    Mater Sci Eng C Mater Biol Appl; 2019 Feb; 95():19-28. PubMed ID: 30573241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.